Research Brief | Altria Study Finds Limited Impact of Massachusetts Flavor Ban on Adult Smoking Rates

Sep.24.2025
Research Brief | Altria Study Finds Limited Impact of Massachusetts Flavor Ban on Adult Smoking Rates
A replication study by Altria scientists published in AJPM Focus evaluated the effect of Massachusetts’ comprehensive flavored‐tobacco ban,the study found that while Massachusetts’ smoking rate continued to decline after the ban, it did not fall faster than in comparison states without flavor bans. Overall, Massachusetts fell from about 14.1% to 10.7%, while comparison states fell from 18.5% to 14.8%. The authors conclude that, for adult smoking prevalence, no additional net decline attributable

The 2025 AJPM Focus paper, “The Behavioral Impact of the Massachusetts Flavored Tobacco Products Ban on Cigarette Smoking Among Adults Aged ≥21 Years,” assessed the ban’s impact using 2017–2022 BRFSS data and a difference-in-differences (DiD) design. Massachusetts (ban in June 2020) served as the treatment group, and U.S. states without flavor bans served as controls. The analysis compared pre- vs post-ban changes in adult smoking rates.

 

Research Brief | Altria Study Finds Limited Impact of Massachusetts Flavor Ban on Adult Smoking Rates
Image source: Altria

 


 

 

Key Findings

 

Overall trend:

 

  • Massachusetts adult smoking: 14.1% (2017) → 10.7% (2022)
  • Comparison states: 18.5% (2017) → 14.8% (2022)
  • Annual decline rates shifted: in Massachusetts, about 6%/year pre-ban slowed to 2%/year post-ban; in comparison states, about 3%/year pre-ban accelerated to 5%/year post-ban.

 

Primary DiD results (adjusted for demographics and year fixed effects):

 

  • Time effect AOR = 1.05 (95% CI: 1.00–1.11, p = 0.0428)
  • Treatment effect AOR = 0.89 (0.84–0.95, p = 0.0002)
  • DiD estimate = 0.94 (0.85–1.03, p = 0.1621) → not significant
  • Multiple sensitivity checks were also not significant (e.g., ≥25 years only: AOR = 0.91, p = 0.0599).
  • Scenario consideration: If roughly one-third of menthol smokers had quit due to the ban, Massachusetts smoking prevalence might have dropped to ≈7% by 2022; such a step-change did not occur.

 

Conclusions

 

With an extended observation window through 2022 and a focus on legal-age adults (≥21), the study did not find evidence that Massachusetts’ flavor ban produced a relative additional decline in adult smoking compared with non-ban states. The authors suggest continued evaluation of initiation, cessation/substitution, DIY flavoring, and illicit supply as potential behavioral and market dynamics that may offset nominal policy effects.

 

Limitations (as stated by the authors)

 

Self-report bias; unobserved, time-varying factors (e.g., state-level COVID-19 responses; Massachusetts’ concurrent tobacco/vaping policies such as temporary EVALI-era sales suspensions, a 75% e-cigarette tax, smoke-free air laws, and funding) may have influenced smoking rates.

 


 

 

Article Information

 

 

Title: The Behavioral Impact of the Massachusetts Flavored Tobacco Products Ban on Cigarette Smoking Among Adults Aged ≥21 Years

Journal: AJPM Focus, 2025, 4(5):100364

Study type: Replication study; Open Access (CC BY-NC-ND)

Authors: Evan A. Winiger, Pavel N. Lizhnyak, Scott W. Drenkard, Andrea R. Vansickel (all with Altria Client Services LLC)

 

 


 

Disclaimer

 

This summary by 2Firsts is based on a publicly available academic paper and is intended to help non-research readers—especially industry practitioners, policymakers, and media—understand the findings and foster dialogue among science, policy, and industry.

 

Unless otherwise indicated, the methods, data, and conclusions presented reflect the original authors’ views. 2Firsts does not endorse those positions and serves only as an information channel.

 

Given possible limitations in our summarization, inaccuracies may exist. Readers are encouraged to consult the original paper for comprehensive details.

 

2Firsts welcomes constructive discussion and critical thinking. No single study answers every question; open and rational dialogue can advance tobacco harm reduction (THR) and improve consumer health outcomes globally.

 

Contact: info@2firsts.com

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK Bill Banning Tobacco Sales to People Born After 2008 Clears Parliament
UK Bill Banning Tobacco Sales to People Born After 2008 Clears Parliament
A UK bill banning the legal sale of tobacco to people born on or after January 1, 2009 has completed its passage through parliament. Under the bill, those born in that group will never be able to be legally sold tobacco anywhere in the UK. The legislation is expected to receive royal assent next week. It also gives ministers powers to strengthen public-place smoking restrictions and restricts branding, promotion and advertising of vape and nicotine products aimed at children.
Apr.22 by 2FIRSTS.ai
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Canada’s Federal Vape Flavor Restrictions Remain Unclear Five Years After Announcement
Canada’s Federal Vape Flavor Restrictions Remain Unclear Five Years After Announcement
Five years after Canada’s federal government announced plans to restrict vaping flavors nationwide, Health Minister Marjorie Michel has not said when or whether the measure will still proceed. In 2021, Health Canada said it planned to limit vaping flavors nationwide to mint, menthol and tobacco, citing evidence that fruity and sweet flavors appeal to youth.
May.11 by 2FIRSTS.ai
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
AI is moving from a back-office tool to a core organizational capability in the nicotine industry. Based on JTI’s responses, this 2Firsts feature examines how AI is reshaping talent strategy, internal mobility, decision-making and human accountability as global tobacco companies compete in the shift toward new nicotine categories.
Jun.17
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
U.S. Smokeless Tobacco Company (USSTC), a subsidiary of Altria Group, announced plans to close its Nashville manufacturing facility by 2028 and consolidate production operations at a new facility in Hopkinsville, Kentucky.
Market
Jun.02
Opinion | As EU Reviews Tobacco Rules, Experts Warn Against Overlooking Smokers’ Alternatives
Opinion | As EU Reviews Tobacco Rules, Experts Warn Against Overlooking Smokers’ Alternatives
As the European Commission reviews its tobacco and advertising rules, two experts who provided written comments to 2Firsts argue that future EU policy should not overlook adult smokers’ alternatives. Dr Garrett McGovern and Dr Carmen Escrig say regulators should weigh relative risk, adult switching, flavours, consumer behaviour and scientific uncertainty alongside youth protection.
Industry Insight
Jun.01